Chemocentryx Stock Valuation

CCXI -  USA Stock  

USD 22.36  0.43  1.89%

Do you want to know what the current value of Chemocentryx is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Chemocentryx, is its stock price multiplied by the total number of shares outstanding, calculating Chemocentryx's enterprise value requires a different approach. It uses Chemocentryx's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
The current Free Cash Flow is estimated to decrease to about (97.1 M). Enterprise Value is estimated to decrease to about 2 B.
Chemocentryx shows a prevailing Real Value of $35.4 per share. The current price of the firm is $22.36. At this time, the firm appears to be undervalued. Our model approximates the value of Chemocentryx from analyzing the firm fundamentals such as return on equity of (39.23) %, and Operating Margin of (403.17) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Refresh
Chemocentryx Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Chemocentryx's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today 22.36
Share
Please note that Chemocentryx's price fluctuation is not too volatile at this time. Calculation of the real value of Chemocentryx is based on 3 months time horizon. Increasing Chemocentryx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chemocentryx is useful when determining the fair value of the Chemocentryx stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chemocentryx. Since Chemocentryx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemocentryx Stock. However, Chemocentryx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
35.40
Real Value
42.37
Upside
Estimating the potential upside or downside of Chemocentryx helps investors to forecast how Chemocentryx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemocentryx more accurately as focusing exclusively on Chemocentryx's fundamentals will not take into account other important factors:
Earnings
Estimates (6)
LowProjected EPSHigh
-1.91-1.66-1.25
Details
Hype
Prediction
LowEstimated ValueHigh
14.8521.8228.79
Details
6 Analysts
Consensus
LowTarget PriceHigh
40.0075.33110.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Chemocentryx's intrinsic value based on its ongoing forecasts of Chemocentryx's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Chemocentryx's closest peers. When choosing an evaluation method for Chemocentryx, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Chemocentryx Investments

255.32 Million

Share

Chemocentryx Valuation Drivers Correlation

Many accounts on the financial statements of Chemocentryx are highly interrelated and sometimes correlated. Consequently, when conducting Chemocentryx's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Chemocentryx
Click cells to compare fundamentals

Chemocentryx Valuation Trend

Knowing Chemocentryx's actual value is paramount for traders to make sound investment determinations. Chemocentryx's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Chemocentryx's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Chemocentryx's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Chemocentryx Market Cap

Chemocentryx is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 1.95 Billion. Chemocentryx totals roughly 1.6 Billion in market capitalization claiming about 82% of stocks in Biotechnology industry.
Capitalization  Total debt  Revenue  Workforce  Valuation

Chemocentryx Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chemocentryx's current stock value. Our valuation model uses many indicators to compare Chemocentryx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemocentryx competition to find correlations between indicators driving Chemocentryx's intrinsic value. More Info.
Chemocentryx is number one stock in beta category among related companies. It is number one stock in price to book category among related companies fabricating about  2.74  of Price to Book per Beta. The current Price to Book Value is estimated to increase to 11.41. Comparative valuation analysis is a catch-all model that can be used if you cannot value Chemocentryx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chemocentryx's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemocentryx's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemocentryx's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemocentryx and how it compares across the competition.

About Chemocentryx Valuation

The equity valuation mechanism determines the current worth of Chemocentryx on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chemocentryx. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chemocentryx based exclusively on its fundamental and basic technical indicators. By analyzing Chemocentryx's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chemocentryx's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chemocentryx. We calculate exposure to Chemocentryx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chemocentryx's related companies.
Last ReportedProjected for 2022
Gross Profit31.9 M37 M
Profit Margin(4.09) (4.41) 
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.

Chemocentryx Quarterly Enterprise Value

1.8 Billion

Share

Chemocentryx Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chemocentryx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio4.20
Revenue Growth-46.90%
Enterprise Value To Ebitda-8.81
Enterprise Value To Revenue34.65

Chemocentryx Current Valuation Indicators

Valuation refers to the process of determining the present value of Chemocentryx and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chemocentryx we look at many different elements of the entity such as Chemocentryx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Chemocentryx's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Chemocentryx's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chemocentryx, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chemocentryx's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chemocentryx's worth.
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Chemocentryx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemocentryx. If investors know Chemocentryx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemocentryx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.